Related Experiment Video
Updated: Aug 5, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Immune Mechanisms Underlying Neonatal Protection Following Maternal RSV Vaccination
Aikaterini I Nikolaou1,2, Vasileios Giapros2, Maria Alexandra Kefala2
1Department of Pediatrics, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
Insights
Maternal respiratory syncytial virus (RSV) vaccination protects newborns via antibodies transferred across the placenta. This review explores how these antibodies, including IgG subclasses and Fc glycosylation, ensure neonatal immunity.
Area of Science:
- Immunology
- Vaccinology
- Neonatal Health
Background:
- Respiratory syncytial virus (RSV) is a leading cause of severe infant respiratory infections.
- Infants possess immunological immaturity, limiting their intrinsic antiviral responses.
- Maternal vaccination offers a promising strategy for neonatal protection against RSV.
Purpose of the Study:
- To review mechanisms of maternally derived antibody-mediated neonatal protection against RSV.
- To elucidate the role of FcRn, IgG subclasses, and Fc glycosylation in antibody transfer and function.
- To identify factors influencing neonatal antibody levels and passive immunity duration.
Main Methods:
- Review of current literature on maternal RSV vaccination and neonatal immunity.
- Analysis of FcRn-mediated transplacental transport mechanisms.
- Examination of IgG subclass-specific transfer and half-life.
- Investigation of Fc glycosylation's role in Fcγ receptor interactions.
Main Results:
- Maternal vaccination induces high-titer, prefusion F-specific IgG1 antibodies for placental transfer.
- FcRn-mediated transport and IgG subclass influence antibody levels and persistence.
- Fc glycosylation impacts Fcγ receptor engagement and Fc-dependent effector functions.
- Both neutralization and Fc-dependent mechanisms contribute to neonatal protection.
Conclusions:
- Understanding antibody transport and effector functions is crucial for optimizing maternal RSV immunization.
- Factors like vaccination timing, antibody characteristics, and placental integrity are key determinants of neonatal immunity.
- Further research is needed to clarify selective placental transfer pathways and optimize strategies for early-life protection.
Abstract:
Respiratory syncytial virus (RSV) remains a major cause of severe lower respiratory tract infection in early infancy, a period characterized by immunological immaturity and limited capacity for effective antiviral responses. Maternal RSV vaccination has emerged as a successful strategy to protect newborns by inducing high concentrations of IgG1-dominant, prefusion F-specific antibodies, which are selectively and actively transported across the placenta. This review synthesizes current mechanistic insights into how maternally derived antibodies confer neonatal protection, focusing on (i) FcRn-mediated transplacental transport, (ii) IgG subclass-specific differences in transfer and half-life, and (iii) the role of Fc glycosylation in modulating Fcγ receptor engagement and effector functions. Beyond neutralization, vaccine-induced antibodies mediate Fc-dependent mechanisms such as antibody-dependent cellular cytotoxicity and phagocytosis, which may be preferentially enriched in the neonatal circulation. Although emerging systems serology data suggest qualitative selectivity in placental transfer, evidence remains heterogeneous and highlights the need for further clarification of glycosylation-dependent and glycosylation-independent pathways. The timing of vaccination, maternal antibody characteristics, and placental integrity critically influence neonatal antibody levels and the duration of passive immunity. Understanding these molecular determinants is essential for optimizing maternal RSV immunization strategies and improving early-life protection.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations
Vaccines
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

